BUSINESS DEVELOPMENT

Leveraging our product development infrastructure, Cabrellis is seeking opportunities to in-license clinical-stage oncology drug candidates with important differentiating properties and clear routes to product registration. Our strategic focus is in innovative cancer treatments for development and commercialization in North America and Europe.

We bring experience in constructive partnership design and in rapid and effective product development. If you have a product or licensing opportunity that you believe would be of interest to us, we encourage you to contact us.